Skip to content

Early Ambulation Safely in Unstable Ankle Fractures (EASY-Ankle)

Early Ambulation Safely in Unstable Ankle Fractures (EASY-Ankle): A Pilot Randomized Controlled Single-Center Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07811804
Acronym
EASY-Ankle
Enrollment
50
Registered
2026-09-10
Start date
2026-09-08
Completion date
2028-06-08
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trimalleolar Ankle Fracture, Unstable Trimalleolar Ankle Fracture

Keywords

Early Weight-Bearing, Delayed Weight-Bearing, Trimalleolar Fracture, ORIF, Weight-Bearing Rehabilitation

Brief summary

This pilot randomized controlled trial will evaluate the safety and feasibility of beginning weight-bearing earlier after surgery for an unstable trimalleolar ankle fracture. Trimalleolar ankle fractures involve three parts of the ankle and usually require surgery to restore and stabilize the joint. After surgery, patients are commonly instructed not to place weight on the injured ankle for approximately six weeks. However, earlier weight-bearing may improve mobility and recovery without increasing complications. Additional evidence is needed specifically for patients with trimalleolar fractures. Participants will be randomly assigned in a 1:1 ratio to one of two postoperative rehabilitation groups. The early weight-bearing group will begin placing weight on the injured ankle two weeks after surgery. The delayed weight-bearing group will begin weight-bearing six weeks after surgery, which reflects the current standard approach. Both groups will begin ankle range-of-motion exercises approximately two weeks after surgery. Participants will be followed for 52 weeks. Ankle function, mobility, quality of life, complications, and routine X-ray findings will be assessed during follow-up. The study will also evaluate participant recruitment, adherence to the assigned rehabilitation protocol, and completeness of study data. The results will help determine whether a larger randomized controlled trial should be conducted and may contribute to future rehabilitation recommendations for patients recovering from surgically treated trimalleolar ankle fractures.

Interventions

OTHERPostoperative Weight-Bearing Rehabilitation Protocol

Participants will be assigned to one of two postoperative rehabilitation protocols following open reduction and internal fixation of an unstable trimalleolar ankle fracture. The Early Weight-Bearing protocol begins weight-bearing as tolerated at 2 weeks after surgery. The Delayed Weight-Bearing protocol begins weight-bearing as tolerated at 6 weeks after surgery. Both groups begin standardized active and passive ankle range-of-motion exercises at 2 weeks postoperatively.

Sponsors

Ottawa Hospital Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Participants and intervention providers cannot be blinded because of the nature of the assigned weight-bearing instructions. Outcome assessments will be conducted by personnel blinded to treatment allocation to the best of the study team's ability.

Intervention model description

Participants are randomized in a 1:1 ratio to one of two parallel postoperative rehabilitation groups: early weight-bearing beginning 2 weeks after surgery or delayed weight-bearing beginning 6 weeks after surgery.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older. * Operative fixation of an unstable trimalleolar ankle fracture, with or without a syndesmotic injury requiring fixation. * Satisfactory anatomical reduction and rigid internal fixation achieved according to established AO principles, including fixation of the posterior malleolus where indicated. * Surgery performed within 14 days of the injury. * Able and willing to provide informed consent.

Exclusion criteria

* Lack of protective sensation, such as peripheral neuropathy. * Unable to adhere to trial procedures. * Bilateral operatively treated ankle fractures. * Treatment of the index fracture with a hindfoot nail. * Morbid obesity, defined as body mass index greater than 40. * Diabetes. * Neuroarthropathy.

Design outcomes

Primary

MeasureTime frameDescription
Participant Recruitment RateThroughout the 12-month recruitment periodFeasibility of recruitment will be assessed using the number and proportion of screened patients who meet the eligibility criteria and the proportion of eligible patients who consent to participate. The protocol identifies an eligibility-rate target of at least 60% and a consent-rate target of at least 30%.
Percentage of Participants Adherent to the Assigned Weight-Bearing ProtocolFrom randomization through 6 weeks after surgeryParticipant adherence will be assessed using self-reported compliance with the assigned early or delayed weight-bearing protocol. Measures will include intervention compliance and crossover between treatment groups. The protocol specifies an intervention-compliance target of at least 90% and a crossover-rate target of no more than 5%.
Completeness of Primary Outcome DataThrough 52 weeks after surgeryFeasibility of data collection will be assessed using the proportion of participants with complete and valid Olerud and Molander Ankle Score data and the proportion lost to follow-up. The protocol specifies a valid primary-outcome-data target of at least 80% and an attrition or loss-to-follow-up target of no more than 15%.
Olerud and Molander Ankle Score at 3 Months12 weeks after surgeryAnkle function will be measured using the Olerud and Molander Ankle Score (OMAS). The OMAS ranges from 0 to 100 points, with higher scores indicating better ankle function and fewer symptoms. Scores will be compared between the Early Weight-Bearing and Delayed Weight-Bearing groups. The score assesses ankle symptoms and the ability to perform activities such as walking, running, jumping, and stair use. The protocol specifies a non-inferiority margin of -8 points.

Secondary

MeasureTime frameDescription
Change in Olerud and Molander Ankle Score6, 12, 26, and 52 weeks after surgeryAnkle function, pain, and ability to perform daily activities will be assessed using the Olerud and Molander Ankle Score. Scores range from 0 to 100, with higher scores indicating better ankle function and fewer symptoms.
Foot and Ankle Ability Measure Score6, 12, 26, and 52 weeks after surgeryFoot and ankle function during daily and more demanding activities will be assessed using the Foot and Ankle Ability Measure. Scores are expressed as a percentage from 0% to 100%, with higher scores indicating better function.
EuroQol 5-Dimension 5-Level Score6, 12, 26, and 52 weeks after surgeryHealth-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level questionnaire. The questionnaire assesses five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension is rated on 5 levels; from 1 indicating no problems to 5 indicating extreme problems or inability to perform the activity. Higher levels indicate greater impairment.
Visual Analog Scale Score6, 12, 26, and 52 weeks after surgeryParticipants' self-reported health status or pain will be assessed using a visual analog scale (VAS) . Pain will be assessed using a 10 cm VAS ranging from 0 cm (no pain) to 10 cm (pain as bad as it could possibly be).
Incidence of Postoperative ComplicationsFrom randomization through 52 weeks after surgeryThe number and proportion of participants experiencing postoperative complications will be recorded. Complications include fracture displacement or loss of reduction, non-union, malunion, infection, symptomatic deep vein thrombosis, pulmonary embolism, and unplanned re-operation.
Incidence of Radiological Loss of Reduction2, 6, 12, 26, and 52 weeks after surgeryRoutine postoperative radiographs will be reviewed for loss of reduction. The protocol defines relevant findings as talar subluxation greater than 2 mm, excessive talar tilt greater than 2 degrees, or tibiofibular clear space of at least 5 mm.

Countries

Canada

Contacts

CONTACTHoda Clinical Research Coordinator
hghaziasgar@ohri.ca613-737-8899
CONTACTMaryam Clinical Research Coordinator
marleclerc@ohri.ca
PRINCIPAL_INVESTIGATORBradley Meulenkamp, MD, MSc, FRCSC

Ottawa Hospital Research Institute

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026